{'fraction_non_alphanumeric': 0.022727272727272728, 'fraction_numerical': 0.0034965034965034965, 'mean_word_length': 5.511363636363637, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Update Research in Psoriasis

Psoriasis is now more recognized as a chronic-lymphocyte mediated inflammatory and proliferous skin disease. In European countries, the prevalence of psoriasis is 1%~3%, so the study of psoriasis is very important. With the study of immune pathogenesis and the progress of genetic engineering technology, it has been gradually developed a wide range of biological agents, And achieved good results in clinical trials or clinical treatment. This paper discusses the typical clinical manifestations, genetic research and treatment of psoriasis.